Early research (Phase 1)Study completedNCT05537038
What this trial is testing
Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in Healthy Volunteers
Who this might be right for
Tuberculosis
BioNTech SE 120